Jasper Therapeutics Inc To Host an Investor Webinar Meeting Transcript
Thank you for standing by. Welcome to the Jasper Therapeutics Data Update Webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Jasper Investor Relations website following the conclusion of the event.
I'd now like to hand the call over to Jasper's Head of Investor Relations, Alex Gray. Please go ahead, Alex.
Thank you, Wilson, and thank you for those listening in today. Joining us for the prepared remarks are Ronald Martell, CEO; Dr. Daniel Adelman, acting CMO; and Dr. Martin Betz, Professor of Dermatology and Allergy at Universitätsmedizin Berlin. Also on the line is Herb Cross, CFO, who will be available during the Q&A session. We will be presenting slides on today's call, which are available via the webinar link and posted to our Investor Relations website.
During today's event, we will be making forward-looking statements based on our estimates and assumptions and our current expectations and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

